Related Experiment Videos
Therapy for Alzheimer's disease: choosing a target
1Department of Pathology, Albert Einstein College of Medicine, Bronx, New York 10461.
Clinical Neuropharmacology
|January 1, 1991
Summary
This review explores Alzheimer's disease (AD) treatments, focusing on symptom alleviation versus disease modification. It examines key biochemical targets for future drug development in Alzheimer's disease research.
Area of Science:
- Neuroscience
- Biochemistry
- Pharmacology
Background:
- Alzheimer's disease (AD) presents complex therapeutic challenges.
- Current treatments primarily aim to alleviate symptoms, with limited success in halting progression.
Purpose of the Study:
- To review major biochemical abnormalities in Alzheimer's disease.
- To evaluate the potential of these abnormalities as therapeutic targets for drug development.
Main Methods:
- Literature review of biochemical abnormalities in Alzheimer's disease.
- Analysis of the merits of targeting specific biochemical pathways for therapeutic intervention.
Main Results:
- Identified key biochemical abnormalities associated with Alzheimer's disease.
- Discussed the challenges in selecting prime targets for effective Alzheimer's disease therapies.
Conclusions:
- Therapeutic strategies for Alzheimer's disease require a deeper understanding of its core biochemical mechanisms.
- Future drug development should consider both symptomatic relief and disease-modifying approaches targeting specific molecular abnormalities.